Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Completed · Phase 2

Conditions studied: Lung Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of vinorelbine taken by mouth in treating older patients who have stage IIIB or stage IV non-small cell lung cancer.

Key facts

Study ID

NCT00008333

Run by

Alliance for Clinical Trials in Oncology

People needed

59

Starts

2001-04-01

Expected to finish

2007-07-01

Last updated by the study team

2016-07-13

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CCOP - Scottsdale Oncology Program — Scottsdale, Arizona, United States
• CCOP - Carle Cancer Center — Urbana, Illinois, United States
• CCOP - Cedar Rapids Oncology Project — Cedar Rapids, Iowa, United States
• Siouxland Hematology-Oncology — Sioux City, Iowa, United States
• CCOP - Wichita — Wichita, Kansas, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• CCOP - Metro-Minnesota — Saint Louis Park, Minnesota, United States
• CCOP - Missouri Valley Cancer Consortium — Omaha, Nebraska, United States
• CCOP - Merit Care Hospital — Fargo, North Dakota, United States
• CCOP - Toledo Community Hospital Oncology Program — Toledo, Ohio, United States
• CCOP - Geisinger Clinic and Medical Center — Danville, Pennsylvania, United States
• Rapid City Regional Hospital — Rapid City, South Dakota, United States
• CCOP - Sioux Community Cancer Consortium — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.